Reid Bengard MBA has run major qualitative and quantitative market research studies for biotechnology and pharmaceutical companies since 1997. His research experience spans dozens of therapeutic categories across established and emerging markets and includes every major stakeholder group from physicians, nurses, pharmacists and patients to payers and thought leaders. Prior to working with groupH, he held senior positions at ZS Associates and Ziment. At ZS Associates, he worked on key product launches for one of the company’s largest clients, integrating both primary and secondary data for pre and post-launch performance analysis. At Ziment, he served as director for west coast clients, where he developed an expertise in target product profile testing. He holds a BSc from the University of California at Davis and an MBA from the Wharton School of the University of Pennsylvania.